Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,155.75. The stock has a price-to-earnings ratio of 40.73 and currently yields dividends of 57.1%.
On 2026-06-08, Eli Lilly(LLY) stock moved within a range of $1,143.60 to $1,182.73. With shares now at $1,155.75, the stock is trading +1.1% above its intraday low and -2.3% below the session's peak.
Trading activity shows a volume of 4.5M, compared to an average daily volume of 3.42M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
Key Points Prevention could become Eli Lilly's next multibillion-dollar growth driver. Antibiotic resistance is increasing demand for preventive vaccine solut...
Key Points Zealand Pharma reported a high drop-out rate in a phase III trial of Survodutide, due to undesirable side effects experienced by patients. That's g...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This Phase 1 study, officially titled “A Phase 1, Open-label Study of the Abso...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support 6/06/2026 Eli Lilly leads three health care stocks to watch as the market appears to be rot...
The stock of Eli Lilly (LLY) is up 4% on June 8 following positive trial data for the company’s newest weight-loss drug called Retatrutide. Unlock trusted, dat...
Key Points Novo Nordisk and Eli Lilly are introducing GLP-1 pills for obesity, and that competition was on display this weekend at the American Diabetes Associa...
Eli Lilly and Co. (NYSE:LLY) on Sunday presented new analyses showing that women with obesity or overweight achieved significant weight loss with Foundayo acros...
Eli Lilly (NYSE:LLY) shares are getting the thumbs up from investors on Monday after new data on its next-generation obesity therapy retatrutide strengthened co...
Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Eli Lilly & Co, retaining the price target of $1,300.00. Evan Seigerman has given his Buy rati...
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could infl...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.